Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Ранг среди акций #20725
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Цена акции
$0.5194
Рыночная капитализация
$125.72M
Изменение (1 день)
-0.12%
Изменение (1 год)
48.40%
Страна
US
Торговля Vaxart, Inc. (VXRT)

Категория

История дроблений акций Vaxart, Inc. (VXRT)
Акции Vaxart, Inc. (символ: VXRT) прошли через 0 дроблений.
Последнее дробление произошло Aug 24, 2026.
Одна акция VXRT, купленная до Aug 24, 2026, сейчас соответствует 0 акциям VXRT.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH